Funding for this research was provided by:
St. Jude Children's Research Hospital (St. Jude Children’s Research Hospital Collaborative Research Consortium on Novel Gene Therapies for Sickle Cell Disease)
Doris Duke Charitable Foundation (2017093)
National Heart, Lung, and Blood Institute (U01HL145793)
First Online: 22 December 2018
: Not applicable for an Opinion article.
: SQT has financial interests in Monitor Biotechnologies. SQT is a co-inventor on patents describing the GUIDE-seq and CIRCLE-seq methods that have been licensed to Monitor Biotechnologies. YC declares that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.